Overview
Comprehensive STI screening may include HIV, syphilis, hepatitis and NAAT testing for chlamydia and gonorrhea, with swabs added when clinically appropriate. It provides broader coverage but is individualized.
What it detects
Multiple STIs depending on selected tests.
Sample type
Blood, urine and/or swabs.
When it may be appropriate
Routine screening, multiple exposures, symptoms or partner diagnosis.
Window period considerations
Each component has its own window period; timing affects reliability.
Test limitations
No panel detects every possible infection; interpretation depends on risk and symptoms.
Interpretation basics
Results guide treatment and follow-up; negative results apply to tested infections and timing.
Follow-up recommendations
Treat positives, repeat testing if needed, and discuss prevention.
Key points
- Broad coverage
- Individualized panel
- Multiple sample types
- Timing matters
When to seek care
- Routine screening
- Multiple exposures
- Unexplained symptoms